NOV 13, 2017 3:19 PM PST

Improving the Detection of Fragile-X Syndrome

WRITTEN BY: Xuan Pham

Image credit: Pixabay.com

Repeat sequences are common in our DNA, and are known to cause human disorders. In particular, a triplet repeat on the X-chromosome is associated with Fragile X syndrome, a collection of abnormalities linked to intellectual disabilities and autism.
 
Because this disorder is a result of repeating nucleotide triplets, diagnosis hinges on knowing precisely how many repeats are present in the patient’s DNA. But current technologies make accurate genetic diagnosis for Fragile X Syndrome (FXS), and other repeat disorders, are complicated and expensive. Now, researchers at the National Institute of Health have unveiled platform that overcomes these obstacles, providing accurate FXS diagnoses in less than 24 hours.

In FXS, the trinucleotide repeat (CGG) is located in the FMR1 gene (aptly named as the fragile X mental retardation 1 gene). For FXS and other repeat disorders, the range of clinical severity is directly associated with the repeat length. Although the exact number of repeats in each range is not concrete, we know that people with between 5-40 repeats do not manifest any symptoms and are considered normal. Patients that have greater than 200 repeats are considered to have a full mutation and clinically develop FXS. However, patients that do not have that high repeat threshold but are above the normal repeat threshold, i.e. between 55-200 CGG repeats, are considered carriers of the permutation and develop Fragile X Tremor/Ataxia Syndrome. 
 
Another important characteristic of these disorders is the instability of these triplet repeats. This means the repeats often increase in length when transmitted to successive generations. Thus, there is genetic anticipation for triplet repeat expansion diseases, making it imperative for patients to know if they are carriers or not.
 
"Careful analysis of the total number of repeats, the number of interruptions in the repeat tract, and the methylation status of the FMR1 gene is important for a proper understanding of an individual's risk of transmission of larger alleles to their offspring and to their personal risk of disease pathology. It is also critical for addressing a number of important research questions," said Karen Usdin, scientist at the NIH and senior author of the study.


Current tests that attempt to amplify the long triplet repeat tracts are difficult and time-consuming. But with the new assays developed by Usdin and her team, the tests are robust enough to amplify up to 1,000 repeats even in samples that have a mixture of different alleles. Furthermore, accurate triplet repeats can be assayed in under 24 hours. In addition, "The basic assays for repeat number, methylation status, and the number of uninterrupted repeats cost less than $5, the mark typically considered the threshold for population-based screening," said Bruce Hayward, first author of the study.
 
The team hopes this assay will also be beneficial to researchers interested in the effect of repeat length in embryonic development and gene expression. It would also be interesting to know if a similar test can be applied to other repeat disorders, like Huntington’s disease.

Additional source: EurekAlert!

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
SEP 25, 2019
Neuroscience
SEP 25, 2019
Nanolaser designed to function in brain tissue
Scientists have developed a nanolaser (miniaturized laser) that can function inside living tissues. According to researchers, the laser is about 1/1,000th the thickness of a single human hair...
NOV 05, 2019
Clinical & Molecular DX
NOV 05, 2019
Meningitis and Encephalitis: Testing & Diagnosis Strategies for Effective Treatment
Meningitis is an inflammation of the membranes surrounding the brain (meninges) and spinal cord. Encephalitis, on the other hand, refers to inflammation of...
NOV 20, 2019
Clinical & Molecular DX
NOV 20, 2019
New diagnostic technology seeks out cancer DNA in blood
For many cancers, early detection has a tremendous impact on patient outcomes. Yet, sadly, many of the most common malignancies, like those of the stomach,...
JAN 07, 2020
Clinical & Molecular DX
JAN 07, 2020
Saliva Test for Early Detection of Mouth and Throat Cancer
“OPC is one of the fastest rising cancers in Western countries due to increasing HPV-related incidence, especially in younger patients. It is paramou...
JAN 21, 2020
Clinical & Molecular DX
JAN 21, 2020
Brain scans of teens predict their risk of binge drinking
We’ve seen teenage binge drinking widely represented in popular culture. There is, however, a dark side to what many consider harmless fun. Mounting...
JAN 19, 2020
Immunology
JAN 19, 2020
Overactive Immune Gene May Cause Schizophrenia
A windy road links excessive activity of the “C4” gene to the development of schizophrenia. Researchers begin to study C4 activity as part of n...
Loading Comments...